Molecular Mechanism of Wilms' Tumor (Wt1) (+/-KTS) Variants Promoting Proliferation and Migration of Ovarian Epithelial Cells by Bioinformatics Analysis

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2023 Feb 24

PMID 36829196

Authors

Xiaomei Wang

Jingyu Zhao

Yixin Zhang

Yuxin Liu

Jinzheng Wang

Ruoxi Shi

Jinxiang Yuan

Kai Meng

Affiliations

Soon will be listed here.

Abstract

Epithelial ovarian cancer (EOC) is a gynecological disease with the highest mortality. With the lack of understanding of its pathogenesis, no accurate early diagnosis and screening method has been established for EOC. Studies revealed the multi-faceted function of Wilms' tumor (Wt1) genes in cancer, which may be related to the existence of multiple alternative splices. Our results show that Wt1 (+KTS) or Wt1 (-KTS) overexpression can significantly promote the proliferation and migration of human ovarian epithelial cells HOSEpiC, and Wt1 (+KTS) effects were more evident. To explore the Wt1 (+/-KTS) variant mechanism in HOSEpiC proliferation and migration and ovarian cancer (OC) occurrence and development, this study explored the differential regulation of Wt1 (+/-KTS) in HOSEpiC proliferation and migration by transcriptome sequencing. OC-related hub genes were screened by bioinformatics analysis to further explore the differential molecular mechanism of Wt1 (+/-KTS) in the occurrence of OC. Finally, we found that the regulation of Wt1 (+/-KTS) variants on the proliferation and migration of HOSEpiC may act through different genes and signaling pathways and screened out key genes and differentially regulated genes that regulate the malignant transformation of ovarian epithelial cells. The implementation of this study will provide new clues for the early diagnosis and precise treatment of OC.

Citing Articles

Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy.

Nian Q, Lin Y, Zeng J, Zhang Y, Liu R Transl Oncol. 2024; 52():102237.

PMID: 39672002 PMC: 11700300. DOI: 10.1016/j.tranon.2024.102237.

An artificial intelligence prediction model based on extracellular matrix proteins for the prognostic prediction and immunotherapeutic evaluation of ovarian serous adenocarcinoma.

Geng T, Zheng M, Wang Y, Reseland J, Samara A Front Mol Biosci. 2023; 10:1200354.

PMID: 37388244 PMC: 10301747. DOI: 10.3389/fmolb.2023.1200354.

References

Hu J, Cai D, Zhao Z, Zhong G, Gong J . Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion Ras/MAPK Signaling Pathway. Front Oncol. 2021; 11:659676. PMC: 8087488. DOI: 10.3389/fonc.2021.659676. View

Haber D, Englert C, Maheswaran S . Functional properties of WT1. Med Pediatr Oncol. 1996; 27(5):453-5. DOI: 10.1002/(SICI)1096-911X(199611)27:5<453::AID-MPO11>3.0.CO;2-B. View

Yang W, Redpath R, Zhang C, Ning N . Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway. Oncol Lett. 2018; 16(3):3365-3372. PMC: 6096146. DOI: 10.3892/ol.2018.9052. View

Padua M, Bhat-Nakshatri P, Anjanappa M, Prasad M, Hao Y, Rao X . Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis. Breast Cancer Res. 2018; 20(1):35. PMC: 5932758. DOI: 10.1186/s13058-018-0963-5. View

Cheng L, Zhang K, Qing Y, Li D, Cui M, Jin P . Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells. J Ovarian Res. 2020; 13(1):9. PMC: 6977352. DOI: 10.1186/s13048-020-0609-y. View

Lheureux S, Braunstein M, Oza A . Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin. 2019; 69(4):280-304. DOI: 10.3322/caac.21559. View

Krishnan H, Rayes J, Miyashita T, Ishii G, Retzbach E, Sheehan S . Podoplanin: An emerging cancer biomarker and therapeutic target. Cancer Sci. 2018; 109(5):1292-1299. PMC: 5980289. DOI: 10.1111/cas.13580. View

Perez-Juarez C, Arechavaleta-Velasco F, Zeferino-Toquero M, Alvarez-Arellano L, Estrada-Moscoso I, Diaz-Cueto L . Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors. Med Oncol. 2019; 37(1):4. DOI: 10.1007/s12032-019-1326-5. View

Bu D, Luo H, Huo P, Wang Z, Zhang S, He Z . KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 2021; 49(W1):W317-W325. PMC: 8265193. DOI: 10.1093/nar/gkab447. View

10.

Meng K, Wang X, He Y, Yang J, Wang H, Zhang Y . The Wilms tumor gene (WT1) (+/-KTS) isoforms regulate steroidogenesis by modulating the PI3K/AKT and ERK1/2 pathways in bovine granulosa cells†. Biol Reprod. 2019; 100(5):1344-1355. DOI: 10.1093/biolre/ioz003. View

11.

Han Y, San-Marina S, Yang L, Khoury H, Minden M . The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Breast Cancer Res. 2007; 9(4):R43. PMC: 2206716. DOI: 10.1186/bcr1743. View

12.

Zhou S, Liang Y, Zhang X, Liao L, Yang Y, Ouyang W . SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway. J Invest Dermatol. 2019; 140(2):395-403.e6. DOI: 10.1016/j.jid.2019.07.696. View

13.

Li B, Liang Z, Seery S, Liu Q, You L, Zhang T . WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. Cancer Lett. 2019; 451:48-57. DOI: 10.1016/j.canlet.2019.02.043. View

14.

Scholz H, Kirschner K . A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda). 2005; 20:54-9. DOI: 10.1152/physiol.00048.2004. View

15.

Wu R, Zhai Y, Fearon E, Cho K . Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 2001; 61(22):8247-55. View

16.

Hu W, Feng P, Zhang M, Tian T, Wang S, Zhao B . Endotoxins Induced ECM-Receptor Interaction Pathway Signal Effect on the Function of MUC2 in Caco2/HT29 Co-Culture Cells. Front Immunol. 2022; 13:916933. PMC: 9226665. DOI: 10.3389/fimmu.2022.916933. View

17.

Burwell E, McCarty G, Simpson L, Thompson K, Loeb D . Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene. 2006; 26(23):3423-30. DOI: 10.1038/sj.onc.1210127. View

18.

Han Y, Song C, Zhang T, Zhou Q, Zhang X, Wang J . Wilms' tumor 1 () promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling. Cell Cycle. 2020; 19(20):2662-2675. PMC: 7644158. DOI: 10.1080/15384101.2020.1817666. View

19.

He S, Deng Y, Liao Y, Li X, Liu J, Yao S . CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer. Oncol Lett. 2017; 14(6):8156-8161. PMC: 5727587. DOI: 10.3892/ol.2017.7234. View

20.

Potluri S, Assi S, Chin P, Coleman D, Pickin A, Moriya S . Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1. Cell Rep. 2021; 35(3):109010. DOI: 10.1016/j.celrep.2021.109010. View